| Entry |
|
|---|
| Name |
Dextroamphetamine (USAN);
Dexamfetamine (INN)
|
|---|
| Formula |
C9H13N
|
|---|
| Exact mass |
135.1048
|
|---|
| Mol weight |
135.2062
|
|---|
| Structure |
     |
|---|
| Activity |
Stimulant [central]
|
|---|
| Remark |
|
|---|
| Comment |
Compoment of Biphetamine (TN)
|
|---|
| Target |
noradrenalin transporter inhibitor [HSA: 6530] [KO: K05035]; dopamine transporter inhibitor [HSA: 6531] [KO: K05036]; serotonin transporter inhibitor [HSA: 6532] [KO: K05037] |
|---|
| Pathway |
|
|---|
| Metabolism |
Enzyme: CYP2D6 [HSA: 1565]
|
|---|
| Interaction |
|
|---|
| Structure map |
| Neurotransmitter transporter inhibitors |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
N06BA Centrally acting sympathomimetics
N06BA02 Dexamfetamine
D03740 Dextroamphetamine (USAN); Dexamfetamine (INN)
USP drug classification [BR:br08302]
Central Nervous System Agents
Attention Deficit Hyperactivity Disorder Agents, Amphetamines
Dextroamphetamine
D03740 Dextroamphetamine (USAN); Dexamfetamine (INN)
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A2 (noradrenalin transporter) [HSA:6530] [KO:K05035]
Dexamfetamine [ATC:N06BA02]
D03740 Dextroamphetamine (USAN); Dexamfetamine (INN)
SLC6A3 (dopamine transporter) [HSA:6531] [KO:K05036]
Dexamfetamine [ATC:N06BA02]
D03740 Dextroamphetamine (USAN); Dexamfetamine (INN)
 |
|---|
| Other DBs |
CAS: 51-64-9 PubChem: DrugBank: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 10
1 C8y C 27.6500 -14.2800
2 C8x C 26.3900 -13.5800
3 C8x C 27.6500 -15.6800
4 C1b C 28.8400 -13.5800
5 C8x C 25.2000 -14.2800
6 C8x C 26.3900 -16.3800
7 C1c C 30.0300 -14.2800
8 C8x C 25.2000 -15.6800
9 C1a C 31.2200 -13.5800
10 N1a N 30.0300 -15.6800
BOND 10
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 2
6 4 7 1
7 5 8 2
8 7 9 1
9 7 10 1 #Down
10 6 8 1
|
|---|
